Karuna Therapeutics Inc

NASDAQ:KRTX   3:59:59 PM EDT
104.36
-1.05 (-1.00%)
Earnings Announcements

Karuna Therapeutics Reports First Quarter 2022 Financial Results And Provides General Business Update

Published: 05/05/2022 11:31 GMT
Karuna Therapeutics Inc (KRTX) - Karuna Therapeutics Reports First Quarter 2022 Financial Results and Provides General Business Update.
Karuna - $443.2 Million in Cash Expected to Fund Operations for at Least 12 Months Following Potential NDA Submission of Karxt for Schizophrenia.
Qtrly Loss per Share 1.95.
Q1 Earnings per Share View $-2.11 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$2.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$2.01

More details on our Analysts Page.